# ACCU-CHEK® Aviva Expert Study: Does Use of a Bolus Advisor Improve Glycemic Control in Patients Not Achieving Optimal Control Using Multiple Daily Injections (MDI)?

> **NCT01460446** · NA · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 218 (actual)

## Conditions studied

- Diabetes Mellitus, Type 1
- Diabetes Mellitus, Type 2

## Interventions

- **DEVICE:** Aviva Expert blood glucose meter
- **DEVICE:** Aviva Nano blood glucose meter

## Key facts

- **NCT ID:** NCT01460446
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10
- **Primary completion:** 2012-09
- **Final completion:** 2012-09
- **Target enrollment:** 218 (ACTUAL)
- **Last updated:** 2014-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01460446

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01460446, "ACCU-CHEK® Aviva Expert Study: Does Use of a Bolus Advisor Improve Glycemic Control in Patients Not Achieving Optimal Control Using Multiple Daily Injections (MDI)?". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01460446. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*